No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
AdAlta Ltd Advances Drug Pipeline Amid Investment Risks
AdAlta Signs Master Services Agreement With Cell Therapies; Shares Up 4%
Biotechnology company AdAlta (ASX:1AD) and Cell Therapies entered into a master services agreement designating Cell Therapies as the company's preferred manufacturing partner of cellular immunotherapi
AdAlta Ltd Applies for New ASX Securities Quotation
AdAlta Ltd. Expands Investment and Partnerships
AdAlta Ltd. Seeks ASX Expansion With New Securities
AdAlta Ltd Hosts Investor Webinar on Growth Funding
No Data